Page 23 - IJB-6-4
P. 23

Shpichka, et al.
           were successfully applied to test siRNA to treat    showed that human recombinant ACE2 prevented
           and  prevent  SARS-CoV  infection .  Moreover,      the virus entry into cells that form blood vessel
                                             [79]
           transgenic  mice  expressing  human  ACE2  can      and kidney organoids . Hoffmann et al. revealed
                                                                                   [8]
           become a great option as ACE2 is one of the main    that Camostat mesylate, a serine protease inhibitor,
           SARS-CoV-2  targets .  Nevertheless,  almost  all   blocked SARS-CoV-2 infection in lung cell line
                               [7]
           animal  models  are  expensive  and  do  not  allow   Calu-3 .
                                                                     [86]
           researchers to fully overcome species specificity     These target enzymes, i.e., ACE2 and TMPR
           for such host-specific virus as well as their use is   SS2,  are  widely  expressed  by  tissues  in  human
           limited because of ethical issues.                  organisms.  ACE2  is  a  monocarboxypeptidase
             Cell-based  models  are  a  good  alternative     that  regulates  the  peptide  cleavage  in  the  renin-
           to  animal  models.  Particularly,  Vero  cell  line   angiotensin system, and high levels of its expression
           cultured  in  2D  conditions  was  used  for  anti-  could be found in alveolar epithelial type II cells,
           SARS-CoV-2  drug  screening .  However,  the        esophagus  keratinocytes,  small  intestine,  ileum
                                        [80]
           main limitation of such cell lines is the deficiency   and rectum enterocytes, stomach epithelial cells,
           of  interferon,  which  is  an  important  regulator   colon  colonocytes,  liver  cholangiocyte,  arterial
           of  binding  proteins  involved  in  SARS-CoV-2     and  venous  endothelial  cells,  arterial  smooth
           infection .  This  requires  the  use  of  other  cell   muscle cells, myocardial cells, sustentacular cells
                   [81]
           types  and  biofabrication  methods  that  would    of  the  olfactory  epithelium,  spermatogonia  and
           better  recapitulate  in vivo  conditions, including   Leydig and Sertoli cells, prostate epithelial cells,
           3D  environment,  flows  dynamics,  and  immune     bladder  urothelial  cells,  and  kidney  proximal
           response.  Moreover,  blood  vessel  and  human     tubules cells [88-94] .  TMPRSS2  regulating  viral
           kidney organoids are still the only 3D models used   uptake by S protein priming is highly expressed
           to study SARS-CoV-2 infection .                     by sustentacular cells of the olfactory epithelium,
                                         [8]
                                                               small  intestine  enterocytes,  bronchial  transient
           4.2 Specific targets                                secretory  cells,  prostate  epithelial  cells,  nasal
           Despite  SARS-CoV-2  is  a  novel  virus  infecting   goblet and ciliated cells, etc. [87,89,95-97] .
           humans,  understanding  of  its  possible  entry    4.3 Key points for the rational design
           mechanisms  was  already  pre-defined  because
           of  earlier  studies  on  other  coronaviruses,  for   Our  lack  of  knowledge  in  the  COVID-19
           example,  SARS-CoV   [82-85] .  Therefore,  after  its   pathogenesis  and  the  absence  of  its  adequate
           appearance,  most  research  teams  have  been      and  licensed  therapy   have  led  to  the  need  to
                                                                                   [2]
           focusing on SARS-CoV receptor ACE2 and other        create novel in vitro platforms that mimic in vivo
           related enzymes. Particularly, Hoffmann et al.      conditions  and  are  specifically  tailored  for  the
                                                        [86]
           proved that the entry of SARS-CoV-2 into a cell     SARS-CoV-2 infection. There is no doubt that 3D
           occurs due to binding of the viral surface spike    tissue models are more suitable than 2D models
           glycoprotein (S protein) to ACE2 and its priming    to  study  any  viral  infections  because  they  share
           by  the  transmembrane  protease  serine  protease   the similarity to the native tissue, organ structure,
           2 (TMPRSS2). Zang et al. also revealed that the     and  physiological  functionality,  and  this  is  also
           transmembrane  protease serine protease 4 plays     applicable to COVID-19.
           a  crucial  role  in  virus  entry  using  human  small   3D tissue-like constructs can be fabricated by
           intestinal enteroids as a model .                   a  huge  variety  of  methods  that  can  be  divided
                                        [87]
             Actually, the entry mechanisms are considered     into  two  main  groups:  Scaffold-based  and
           the main targets for designing drugs treating and   scaffold-free.  However,  scaffold-free  techniques
           preventing  COVID-19.  Hence,  their  inhibition    such  as  bioprinting  and  cell  self-organization
           can block the infection that was proven to be true   (spheroidogenesis  and  organoidogenesis)  and
           in  several  studies.  For  instance,  Monteil  et  al.   their combinations are considered to be the most

                                       International Journal of Bioprinting (2020)–Volume 6, Issue 4        19
   18   19   20   21   22   23   24   25   26   27   28